Postmarket surveillance data revealed that enfortumab vedotin (EV) skin toxicity is associated with high hospitalization and ...

The activation and deactivation of apoptosis is a promising field of research in basic biomedical research. The team led by Prof. Franz Hagn from the Chair of Structural Membrane Biochemistry at the ...

Ivonescimab is a next-generation bispecific antibody that simultaneously targets programmed cell death protein 1 (PD-1) and vascular endothelial growth factor (VEGF), two key molecules in the tumour ...

In the fight against disease, programmed cell death, also known as apoptosis, is a key protective function of the body. A ...

The use of immunotherapy in patients with various types of cancer has led to dramatic increases in survival. Increased median ...

A team of researchers at the University of Cologne's Center for Biochemistry, together with the Bambino Gesù Pediatric Hospital in Rome, Italy, have discovered a fundamental biological mechanism that ...

A recent trial evaluates the impact of dostarlimab on ovarian cancer treatment, revealing modest benefits and no significant ...

LANZHOU -- Chinese researchers have revealed the heart-protective effect of nicotinamide — a derivative of B vitamins — in ...

In the fight against disease, programmed cell death - also known as apoptosis - is a key protective function of the body. It breaks down cells that ...

When pathogens enter our cells as part of an infection, our body will trigger a programmed cell death known as "pyroptosis" ...

Immune checkpoint inhibitors, popularized by Allison and Honjo’s Nobel Prize, were one of the first cancer immunotherapies that gained FDA approval. In the 1990s, Allison and Honjo identified the ...